Human Genome Epidemiology Literature Finder
Records 1 - 5 (of 5 Records) |
Query Trace: Testicular Neoplasms and SRD5A2[original query] |
---|
Variations in testosterone pathway genes and susceptibility to testicular cancer in Norwegian men. International journal of andrology 2012 Dec 35 (6): 819-27. Kristiansen W, Aschim E L, Andersen J M, Witczak O, Fosså S D, Haugen T |
Genetic variations associated with the effect of testicular cancer treatment on gonadal hormones. Human reproduction (Oxford, England) 2014 Dec 29 (12): 2844-51. Aschim E L, Oldenburg J, Kristiansen W, Giwercman A, Witczak O, Fosså S D, Haugen T |
Re: Single-Nucleotide Polymorphism in the 5-a-Reductase Gene (SRD5A2) is Associated with Increased Prevalence of Metabolic Syndrome in Chemotherapy-Treated Testicular Cancer Survivors. The Journal of urology 2016 12 196 (6): 1677-1678. Richie Jerome |
Single-nucleotide polymorphism in the 5-a-reductase gene (SRD5A2) is associated with increased prevalence of metabolic syndrome in chemotherapy-treated testicular cancer survivors. European journal of cancer (Oxford, England : 1990) 2016 Jan 54 104-111. Boer Hink, Westerink Nico-Derk L, Altena Renske, Nuver Janine, Dijck-Brouwer D A Janneke, van Faassen Martijn, Klont Frank, Kema Ido P, Lefrandt Joop D, Zwart Nynke, Boezen H Marike, Smit Andries J, Meijer Coby, Gietema Jourik |
Clinical and Genetic Risk Factors for Adverse Metabolic Outcomes in North American Testicular Cancer Survivors. Journal of the National Comprehensive Cancer Network : JNCCN 2018 Mar 16 (3): 257-265. Zaid Mohammad Abu, Gathirua-Mwangi Wambui G, Fung Chunkit, Monahan Patrick O, El-Charif Omar, Williams Annalynn M, Feldman Darren R, Hamilton Robert J, Vaughn David J, Beard Clair J, Cook Ryan, Althouse Sandra K, Ardeshir-Rouhani-Fard Shirin, Dinh Paul C, Sesso Howard D, Einhorn Lawrence H, Fossa Sophie D, Travis Lois B, |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 06, 2024
- Content source: